标题
Methotrexate Is a JAK/STAT Pathway Inhibitor
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 7, Pages e0130078
出版商
Public Library of Science (PLoS)
发表日期
2015-07-02
DOI
10.1371/journal.pone.0130078
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells
- (2014) U. Rozovski et al. BLOOD
- Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts
- (2014) F. Passamonti et al. BLOOD
- Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012
- (2014) John T. Reilly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Should myeloid and lymphoid neoplasms withPCM1-JAK2and other rearrangements ofJAK2be recognized as specific entities?
- (2014) Barbara J. Bain et al. BRITISH JOURNAL OF HAEMATOLOGY
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
- (2014) Allison Rosenthal et al. EXPERT OPINION ON PHARMACOTHERAPY
- Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia
- (2013) L. S. Hodge et al. BLOOD
- JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
- (2013) W. Warsch et al. BLOOD
- Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia
- (2013) S. Radtke et al. BLOOD
- A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
- (2013) Srdan Verstovsek et al. CANCER
- Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
- (2013) R. A. Mesa et al. HAEMATOLOGICA
- Drosophila SOCS36E negatively regulates JAK/STAT pathway signaling via two separable mechanisms
- (2013) Wojciech Stec et al. MOLECULAR BIOLOGY OF THE CELL
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal
- (2013) Ros Wade et al. PHARMACOECONOMICS
- Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice
- (2012) C. Walz et al. BLOOD
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia
- (2012) A. Jerez et al. BLOOD
- Advances in genome-wide RNAi cellular screens: a case study using the Drosophila JAK/STAT pathway
- (2012) Katherine H Fisher et al. BMC GENOMICS
- A Randomized, Double-Blind, Parallel, Single-Site Pilot Trial to Compare Two Different Starting Doses of Methotrexate in Methotrexate-Naïve Adult Patients with Rheumatoid Arthritis
- (2012) Eva-Luise Hobl et al. CLINICAL THERAPEUTICS
- The Antifolates
- (2012) Michele Visentin et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms
- (2011) S. Anand et al. BLOOD
- How I treat LGL leukemia
- (2010) T. Lamy et al. BLOOD
- Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans
- (2010) A. D. Shilling et al. DRUG METABOLISM AND DISPOSITION
- MS-1020 is a novel small molecule that selectively inhibits JAK3 activity
- (2009) Byung-Hak Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of recombinant erythropoietins: is there unity of international units?
- (2009) W. Jelkmann NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cytokine Signaling Modules in Inflammatory Responses
- (2008) John J. O'Shea et al. IMMUNITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started